Sinovac Biotech Ltd (SVA) — Free Cash Flow Generation Index
Sinovac Biotech Ltd (SVA) has a Free Cash Flow Generation Index of 0.64x as of December 2023. Free cash flow of $93.26 Million represents 1% of operating cash flow ($146.01 Million). Explore SVA capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinovac Biotech Ltd Free Cash Flow Generation Index (2007–2023)
Historical FCF Generation Index trend for Sinovac Biotech Ltd across 12 annual periods. For the full cash flow conversion analysis, see Sinovac Biotech Ltd (SVA) cash conversion ratio.
Annual Free Cash Flow Generation for Sinovac Biotech Ltd (2007–2023)
Year-by-year Free Cash Flow Generation Index for Sinovac Biotech Ltd. Check SVA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.39x | $-41.69 Million | $106.02 Million | $145.69 Million | ▼ -141.3% |
| 2021 | 0.95x | $14.63 Billion | $15.35 Billion | $719.98 Million | ▲ +29.9% |
| 2020 | 0.73x | $351.66 Million | $479.31 Million | $127.65 Million | ▲ +0.8% |
| 2019 | 0.73x | $28.45 Million | $39.07 Million | $10.63 Million | ▲ +148.2% |
| 2018 | 0.29x | $2.33 Million | $7.94 Million | $5.61 Million | ▼ -63.4% |
| 2017 | 0.80x | $47.84 Million | $59.76 Million | $11.91 Million | ▲ +409.9% |
| 2015 | -0.26x | $-1.09 Million | $4.21 Million | $5.30 Million | ▼ -425.2% |
| 2013 | 0.08x | $443.00K | $5.58 Million | $5.13 Million | ▲ +172.8% |
| 2011 | -0.11x | $-1.52 Million | $13.94 Million | $15.46 Million | ▼ -112.0% |
| 2009 | 0.91x | $44.09 Million | $48.41 Million | $4.32 Million | ▲ +46.6% |
| 2008 | 0.62x | $6.53 Million | $10.50 Million | $3.98 Million | ▲ +45.0% |
| 2007 | 0.43x | $1.85 Million | $4.32 Million | $2.47 Million | — |